Skip to content
Home/Companies/Biotech/Nostos Genomics
Nostos Genomics

Nostos Genomics

Biotech·Germany·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Nostos Genomics?

Nostos Genomics is currently owned by 42CAP through 42CAP II (2019 vintage), since 2022.

Hand-verified · updated 2026-07-16

42CAP
Investor
42CAP
42CAP II · 2019 · VC

Key facts

HQGermany
SectorBiotech
StatusActive
Websitewww.nostos-genomics.com

More from 42CAP II

Other portfolio companies in the same fund.

Cognee
Active
AI/MLGermany· 2026
SimplyBlock
SimplyBlock
Active
Cloud InfrastructureGermany· 2024
DBTune
Active
Data & AnalyticsSweden· 2023
Inceptron
Inceptron
Active
Deep TechSweden· 2023
KYP.ai
Active
Data & AnalyticsGermany· 2023
Osavul
Osavul
Active
CybersecurityUkraine· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Nostos Genomics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Nostos Genomics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue